A peripheral lipid sensor GPR120 remotely contributes to suppression of PGD 2 -microglia-provoked neuroinflammation and neurodegeneration in the mouse hippocampus
Neuroinflammation is a key pathological component of neurodegenerative disease and is characterized by microglial activation and the secretion of proinflammatory mediators. We previously reported that a surge in prostaglandin D (PGD ) production and PGD -induced microglial activation could provoke n...
Gespeichert in:
Veröffentlicht in: | Journal of neuroinflammation 2021-12, Vol.18 (1), p.304 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Neuroinflammation is a key pathological component of neurodegenerative disease and is characterized by microglial activation and the secretion of proinflammatory mediators. We previously reported that a surge in prostaglandin D
(PGD
) production and PGD
-induced microglial activation could provoke neuroinflammation. We also reported that a lipid sensor GPR120 (free fatty acid receptor 4), which is expressed in intestine, could be activated by polyunsaturated fatty acids (PUFA), thereby mediating secretion of glucagon-like peptide-1 (GLP-1). Dysfunction of GPR120 results in obesity in both mice and humans.
To reveal the relationship between PGD
-microglia-provoked neuroinflammation and intestinal PUFA/GPR120 signaling, we investigated neuroinflammation and neuronal function with gene and protein expression, histological, and behavioral analysis in GPR120 knockout (KO) mice.
In the current study, we discovered notable neuroinflammation (increased PGD
production and microglial activation) and neurodegeneration (declines in neurogenesis, hippocampal volume, and cognitive function) in GPR120 KO mice. We also found that Hematopoietic-prostaglandin D synthase (H-PGDS) was expressed in microglia, microglia were activated by PGD
, H-PGDS expression was upregulated in GPR120 KO hippocampus, and inhibition of PGD
production attenuated this neuroinflammation. GPR120 KO mice exhibited reduced intestinal, plasma, and intracerebral GLP-1 contents. Peripheral administration of a GLP-1 analogue, liraglutide, reduced PGD
-microglia-provoked neuroinflammation and further neurodegeneration in GPR120 KO mice.
Our results suggest that neurological phenotypes in GPR120 KO mice are probably caused by dysfunction of intestinal GPR120. These observations raise the possibility that intestinal GLP-1 secretion, stimulated by intestinal GPR120, may remotely contributed to suppress PGD
-microglia-provoked neuroinflammation in the hippocampus. |
---|---|
ISSN: | 1742-2094 |
DOI: | 10.1186/s12974-021-02361-2 |